0001822931-22-000001.txt : 20220414 0001822931-22-000001.hdr.sgml : 20220414 20220414125434 ACCESSION NUMBER: 0001822931-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20220414 DATE AS OF CHANGE: 20220414 EFFECTIVENESS DATE: 20220414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Emerging Markets Healthcare Partners International Ltd. CENTRAL INDEX KEY: 0001822931 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-374631 FILM NUMBER: 22826645 BUSINESS ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY CITY: CAMANA BAY, GRAND CAYMAN STATE: E9 ZIP: KY1-9009 BUSINESS PHONE: (345) 949-9876 MAIL ADDRESS: STREET 1: C/O OGIER GLOBAL (CAYMAN) LIMITED STREET 2: 89 NEXUS WAY CITY: CAMANA BAY, GRAND CAYMAN STATE: E9 ZIP: KY1-9009 D/A 1 primary_doc.xml X0708 D/A LIVE 0001822931 Emerging Markets Healthcare Partners International Ltd. C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY, GRAND CAYMAN E9 CAYMAN ISLANDS KY1-9009 (345) 949-9876 CAYMAN ISLANDS None None Other Cayman Islands Exempted Company true 2020 Samuel D. Isaly Exome Asset Management LLC 444 Madison Avenue, 39th Floor New York NY NEW YORK 10022 Director Promoter Carlos Manuel Godoy Exome Asset Management LLC 444 Madison Avenue, 39th Floor New York NY NEW YORK 10022 Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001822931-21-000001 2020-09-01 true true true false 1000000 Fairview Securities, Inc. 35703 Fairview Securities, Inc. 35703 154 Long Lots Road Westport CT CONNECTICUT 06880 FL FLORIDA TX TEXAS false Indefinite 2652365 Indefinite false 8 866 0 0 Customary advisory fees will be paid to the Investment Manager at the master fund level as provided for in the Issuer's offering materials. false Emerging Markets Healthcare Partners International Ltd. Samuel D. Isaly Samuel D. Isaly Director 2022-04-14